Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival by Binquan Luan (1288623)

“…The highly infectious SARS-CoV-2 variant B.1.351 that first emerged in South Africa with triple mutations (N501Y, K417N, and E484K) is globally worrisome. …”

Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival by Binquan Luan (1288623)

“…The highly infectious SARS-CoV-2 variant B.1.351 that first emerged in South Africa with triple mutations (N501Y, K417N, and E484K) is globally worrisome. …”

Epigenetic regulator expression in individual human blastocysts by qPCR (n = 12 replicates for each group). by Blair R. McCallie (2822252)

Table_5_Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-α Release Mediated by Mycoplasma pneumoniae.xlsx by Ming Chen (115604)

Identification of genetic interactions with <i>yox1 yhp1</i> mutant strains. by Michelle M. Conti (13514386)

The role of local gut response in controlling the loads of <i>Lactobacillus</i> (L) and <i>Acetobacter</i> (A) in P0 pupae and pharate adults. by Catarina Nunes (3542330)

“…<i>108); One-way Wilcoxon test for median<0</i>: <i><2</i>.<i>2e-16</i>, <i>r = 0</i>.<i>866</i>) and <i>Acetobacter</i> <b>(D)</b> (<i>Median</i>: <i>-1</i>.…”

Results of trend, cross correlations analyses for fPAR-MEI, fPAR-SST, and mean fPAR for the time series. by Janet J. Reimer (731511)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Comparison of the protein level and fluorescent intensity between EGFP and sfGFP expressed from the <i>C. merolae</i> genome. by Nobuko Sumiya (648113)

Basal transcriptional activities of the upstream region of <i>CMJ101C orf</i> at lower temperatures in the stable transformants. by Nobuko Sumiya (648113)

Duration-dependent effect of 50°C heat shock on the mRNA and protein levels in the stable transformants. by Nobuko Sumiya (648113)

Optimum temperature for heat shock inducible expression in the stable transformants. by Nobuko Sumiya (648113)

Patterns of <i>CMJ101C</i> mRNA induced expression by heat shock. by Nobuko Sumiya (648113)

Change in the levels of <i>GFP</i> mRNA and GFP protein after 1-h 50°C heat shock in the stable transformants. by Nobuko Sumiya (648113)

The association between consistent habitual running or walking and a slow trajectory of estimated GFR decline (quartile 1)^b'*'. by Ronit Calderon-Margalit (584756)

Parameter estimates from the final models for <i>M</i>. <i>mercenaria</i> & <i>M</i>. <i>arenaria</i> mortality. by Teagan McMahon (20108036)